» Articles » PMID: 38355186

Predictors of Mortality in Hospitalised Patients with COVID-19: a 1-year Case-control Study

Abstract

Background: A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature.

Objectives: To determine the associated factors with mortality, in addition to age and sex during the first year of the pandemic.

Design: A case-control study with retrospective revision of clinical and paraclinical variables by systematic revision of clinical records was conducted. Multiple imputations by chained equation were implemented to account for missing variables. Classification and regression trees (CART) were estimated to evaluate the interaction of associated factors on admission and their role in predicting mortality during hospitalisation. No intervention was performed.

Setting: High-complexity centre above 2640 m above sea level (masl) in Colombia.

Participants: A population sample of 564 patients admitted to the hospital with confirmed COVID-19 by PCR. Deceased patients (n=282) and a control group (n=282), matched by age, sex and month of admission, were included.

Main Outcome Measure: Mortality during hospitalisation.

Main Results: After the imputation of datasets, CART analysis estimated 11 clinical profiles based on respiratory distress, haemoglobin, lactate dehydrogenase, partial pressure of oxygen to inspired partial pressure of oxygen ratio, chronic kidney disease, ferritin, creatinine and leucocytes on admission. The accuracy model for prediction was 80.4% (95% CI 71.8% to 87.3%), with an area under the curve of 78.8% (95% CI 69.63% to 87.93%).

Conclusions: This study discloses new interactions between clinical and paraclinical features beyond age and sex influencing mortality in COVID-19 patients. Furthermore, the predictive model could offer new clues for the personalised management of this condition in clinical settings.

Citing Articles

Pregnancy and COVID-19: Comparing ICU Outcomes for Pregnant and Nonpregnant Women.

Lipinska-Gediga M, Gozdzik W, Smiechowicz J, Adamik B Viruses. 2025; 17(1).

PMID: 39861839 PMC: 11768449. DOI: 10.3390/v17010051.


Predictors of 2-year mortality in geriatric patients hospitalized with COVID-19 in Türkiye: a retrospective cohort study.

Bektan Kanat B, Avci G, Bayramlar O, Suzan V, Can G, Balkan I Biomark Med. 2024; 18(10-12):555-565.

PMID: 39140394 PMC: 11364071. DOI: 10.1080/17520363.2024.2352416.

References
1.
Chen C, Zhang X, Ju Z, He W . [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019]. Zhonghua Shao Shang Za Zhi. 2020; 36(6):471-475. DOI: 10.3760/cma.j.cn501120-20200224-00088. View

2.
Parohan M, Yaghoubi S, Seraji A, Hassan Javanbakht M, Sarraf P, Djalali M . Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020; 23(5):1416-1424. DOI: 10.1080/13685538.2020.1774748. View

3.
Alonso R, Camon A, Cardozo C, Albiach L, Aguero D, Marcos M . Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study. Infect Dis Ther. 2022; 11(3):1243-1251. PMC: 9043505. DOI: 10.1007/s40121-022-00623-x. View

4.
Gandhi R, Lynch J, Del Rio C . Mild or Moderate Covid-19. N Engl J Med. 2020; 383(18):1757-1766. DOI: 10.1056/NEJMcp2009249. View

5.
Pal K, Molnar A, Hutanu A, Szederjesi J, Branea I, Timar A . Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. Int J Mol Sci. 2022; 23(18). PMC: 9499352. DOI: 10.3390/ijms231810423. View